| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
12.07.2010 US 363507 P
|
| (43) |
Date of publication of application: |
|
22.05.2013 Bulletin 2013/21 |
| (73) |
Proprietor: Pfizer Healthcare Ireland |
|
Dublin 24 (IE) |
|
| (72) |
Inventors: |
|
- BHAT, Abhijit Suresh
San Diego, CA 92121 (US)
- BRADSHAW, Curt William
San Diego, CA 92127 (US)
- LAURENT, Olivier Alexandre
San Diego, CA 92121 (US)
- PRESTON, Richard Ryan
San Diego, CA 92121 (US)
- TUMELTY, David
San Diego, CA 92121 (US)
- WOOD, Lauren Diane
San Diego, CA 92121 (US)
- YU, Wei Hong
San Diego, CA 92121 (US)
- LEE, Alice
San Diego, CA 92121 (US)
|
| (74) |
Representative: Pfizer |
|
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR) |
| (56) |
References cited: :
WO-A1-2009/136352
|
WO-A2-2008/056346
|
|
| |
|
|
- HUANG HANHUA ET AL: "Angiopoietin-2 antagonistic CovX-BodyTM inhibits tumor growth
and reduces microvessel density", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN
ASSOCIATION FOR CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol.
48, 1 April 2007 (2007-04-01), page 509, XP001536926, ISSN: 0197-016X
- Rosen et al.: "First-in-human dose-escalation safety and PK trial of a novel intravenous
humanized monoclonal CovX body inhibiting angiopoietin 2. Abstract 2524", Internet
Journal of Clinical Oncology, vol. 28, no. 15 20 May 2010 (2010-05-20), XP002663786,
Retrieved from the Internet: URL:http://meeting.ascopubs.org/cgi/conten t/abstract/28/15_suppl/2524?sid=e726c48d-a
861-4011-b449-b0f58a4956ba [retrieved on 2011-11-17]
- V. R. DOPPALAPUDI ET AL: "Chemical generation of bispecific antibodies", PROCEEDINGS
OF THE NATIONAL ACADEMY OF SCIENCES, vol. 107, no. 52, 28 December 2010 (2010-12-28),
pages 22611-22616, XP55003821, ISSN: 0027-8424, DOI: 10.1073/pnas.1016478108
- HUANG HANHUA ET AL: "Specifically targeting angiopoietin-2 inhibits angiogenesis,
Tie2-expressing monocyte infiltration, and tumor growth.", CLINICAL CANCER RESEARCH
: AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 MAR 2011 LNKD-
PUBMED:21233403, vol. 17, no. 5, 1 March 2011 (2011-03-01), pages 1001-1011, XP002663787,
ISSN: 1078-0432
- HERBST ROY S ET AL: "Safety, pharmacokinetics, and antitumor activity of AMG 386,
a selective angiopoietin inhibitor, in adult patients with advanced solid tumors",
JOURNAL OF CLINICAL ONCOLOGY, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US, vol. 27,
no. 21, 20 July 2009 (2009-07-20) , pages 3557-3565, XP002613992, ISSN: 0732-183X,
DOI: 10.1200/JCO.2008.19.6683
- HUANG HANHUA ET AL: "Targeting the ANGPT-TIE2 pathway in malignancy.", NATURE REVIEWS.
CANCER AUG 2010 LNKD- PUBMED:20651738, vol. 10, no. 8, August 2010 (2010-08), pages
575-585, XP002663788, ISSN: 1474-1768
|
|
